NUCORION PHARMACEUTICALS INC has a total of 20 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are INVIVOGEN, UNIV LA HABANA and HEFEI COSOURCE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | Taiwan | 2 | |
#6 | Australia | 1 | |
#7 | Canada | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies | |
#5 | Special acyclic compounds | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Zhi Lin | 13 |
#2 | Suo Zucai | 7 |
#3 | Taggart David J | 4 |
#4 | Cao Sheng | 2 |
#5 | Vyavhare Vinod P | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021011692A1 | Cyclic deoxyribonucleotide compounds | |
US2020399227A1 | 5-fluorouracil compounds | |
CN111801339A | 5-fluorouracil compounds | |
KR20200108330A | Phosphor (phosphorone) amidatacetal and phosph (one) atalcetal compounds | |
US2019100551A1 | 5-fluorouridine monophosphate cyclic triester compounds | |
US2017088573A1 | Gemcitabine analogs | |
US2016052952A1 | Substituted gemcitabine bicyclic amide analogs and treatment methods using same | |
US2015259375A1 | Substituted gemcitabine aryl amide analogs |